Series A - Aer Therapeutics
Investment Firm
Overview
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Announced Date
Apr 13, 2023
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Hatteras Venture Partners |
Round Details and Background
Aer Therapeutics raised $36000000 on 2023-04-13 in Series A
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 13, 2023 |  Series A - Aer Therapeutics | 3 | - | 36.0M |
Recent Activity
There is no recent news or activity for this profile.